Natural products as inhibitors of recombinant cathepsin L of Leishmania mexicana

被引:27
作者
de Sousa, Lorena R. F. [1 ,2 ]
Wu, Hongmei [2 ]
Nebo, Liliane [1 ]
Fernandes, Joao B. [1 ]
da Silva, Maria F. das G. F. [1 ]
Kiefer, Werner [2 ]
Schirmeister, Tanja [2 ]
Vieira, Paulo C. [1 ]
机构
[1] Univ Fed Sao Carlos, Dept Chem, BR-13565905 Sao Carlos, SP, Brazil
[2] Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, D-55128 Mainz, Germany
关键词
Cathepsin L; Leishmania mexicana; rCPB2.8; Biflavonoid; Triterpene; CYSTEINE PROTEASE INHIBITORS; GARCINIA-BRASILIENSIS; PROTEINASE-INHIBITORS; IN-VITRO; BIFLAVONOIDS; FLAVONOIDS; QUERCETIN; VIRULENCE; CPB; IDENTIFICATION;
D O I
10.1016/j.exppara.2015.05.016
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Cysteine proteinases (cathepsins) from Leishmania spp. are promising molecular targets against leishmaniasis. Leishmania mexicana cathepsin L is essential in the parasite life cycle and a pivotal in virulence factor in mammals. Natural products that have been shown to display antileishmanial activity were screened as part of our ongoing efforts to design inhibitors against the L mexicana cathepsin L-like rCPB2.8. Among them, agathisflavone (1), tetrahydrorobustaflavone (2), 3-oxo-urs-12-en-28-oic acid (3), and quercetin (4) showed significant inhibitory activity on rCPB2.8 with IC50 values ranging from 0.43 to 18.03 mu M. The mechanisms of inhibition for compounds 1-3, which showed K-i values in the low micromolar range (K-i= 0.14-1.26 mu M), were determined. The biflavone 1 and the triterpene 3 are partially noncompetitive inhibitors, whereas biflavanone 2 is an uncompetitive inhibitor. The mechanism of action established for these leishmanicidal natural products provides a new outlook in the search for drugs against Leishmania. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:42 / 48
页数:7
相关论文
共 62 条
[1]   Leishmania panamensis infection and antimonial drugs modulate expression of macrophage drug transporters and metabolizing enzymes: impact on intracellular parasite survival [J].
Adelaida Gomez, Maria ;
Navas, Adriana ;
Marquez, Ricardo ;
Jimena Rojas, Laura ;
Alejandro Vargas, Deninson ;
Manuel Blanco, Victor ;
Koren, Roni ;
Zilberstein, Dan ;
Gore Saravia, Nancy .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (01) :139-149
[2]   In Vitro Antiprotozoal Activity of Triterpenoid Constituents of Kleinia odora Growing in Saudi Arabia [J].
Al Musayeib, Nawal M. ;
Mothana, Ramzi A. ;
El Gamal, Ali A. ;
Al-Massarani, Shaza M. ;
Maes, Louis .
MOLECULES, 2013, 18 (08) :9207-9218
[3]  
Alexander J, 1998, J IMMUNOL, V161, P6794
[4]   Why strategies to control Leishmania spp. multiplication based on the use of proteinase inhibitors should consider multiple targets and not only a single enzyme [J].
Alves, Carlos Roberto ;
Santini Pereira, Bernardo Acacio ;
Silva-Almeida, Mariana ;
da Silva, Franklin Souza .
JOURNAL OF MOLECULAR MODELING, 2014, 20 (10)
[5]   FLAVONOIDS AND OTHER BIOACTIVE PHENOLICS ISOLATED FROM Cenostigma macrophyllum (LEGUMINOSAE) [J].
Alves, Clayton Q. ;
David, Jorge M. ;
David, Juceni P. ;
Villareal, Cristiane F. ;
Soares, Milena B. P. ;
de Queiroz, Luciano P. ;
Aguiar, Rosane M. .
QUIMICA NOVA, 2012, 35 (06) :1137-1140
[6]   Identification of peptides inhibitory to recombinant cysteine proteinase, CPB, of Leishmania mexicana [J].
Alves, LC ;
St Hilaire, PM ;
Meldal, M ;
Sanderson, SJ ;
Mottram, JC ;
Coombs, GH ;
Juliano, L ;
Juliano, MA .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 2001, 114 (01) :81-88
[7]  
[Anonymous], 2006, GRAFIT REG 5 0 13
[8]  
[Anonymous], 2014, Leishmaniasis
[9]   Human leishmaniasis: Clinical, diagnostic, and chemotherapeutic developments in the last 10 years [J].
Berman, JD .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (04) :684-703
[10]  
Bisswanger H., 2008, ENZYME KINETICS PRIN, P111